The expression level of hsa-miR-146a-5p in plasma-derived exosomes of patients with diffuse large B-cell lymphoma

BACKGROUND: The standard treatment for patients with diffuse large B-cell lymphoma (DLBCL) had been rituximab-based immunochemotherapy. However, the biological and clinical heterogeneity within DLBCL seems to affect treatment outcome. Therefore, the evaluation of miRNA levels might be useful in pred...

Descripción completa

Detalles Bibliográficos
Autores principales: Zare, Nasrin, Eskandari, Nahid, Mehrzad, Valiollah, Javanmard, Shaghayegh Haghjooy
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Medknow Publications & Media Pvt Ltd 2019
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6421886/
https://www.ncbi.nlm.nih.gov/pubmed/30988678
http://dx.doi.org/10.4103/jrms.JRMS_507_18

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6421886/
https://www.ncbi.nlm.nih.gov/pubmed/30988678
http://dx.doi.org/10.4103/jrms.JRMS_507_18

Ejemplares similares